COMPOSITION COMPRISING FERRIC SACCHARATE AND HIGH CONCENTRATIONS OF MICROENCAPSULATED LC-PUFA WITH A REDUCED OFF TASTE
The present invention is directed to compositions, preferably nutritional compositions, preferably for infant, children, maternal, ageing care, elderly or health care nutrition. The present invention is further directed to pharmaceutical and/or nutraceutical compositions. The inventive compositions described herein preferably have a neutral or acidic pH, preferably a pH ranging from about 3 to about 7.5, said compositions being fortified with a high concentration of ferric saccharate and a high concentration of microencapsulated long chain-polyunsaturated fatty acids (LC-PUFA), preferably microencapsulated in a glassy matrix of dairy proteins and glucose. Preferably the inventive composition also comprises an antioxidant which is a radical scavenger, preferably along with a non-sensitive oil, said oil most preferably comprising medium chain triglycerides. The present invention also describes a method for preparing such compositions and the use of such compositions, preferably in the treatment of diseases as defined herein.
1 . A composition fortified with ferric saccharate and a high concentration of microencapsulated LC-PUFA.
2 . The composition according to claim 1 wherein the LC-PUFA is present in about 0.02 to 10% by weight of the composition.
3 . The composition according to claim 1 , wherein the LC-PUFA is microencapsulated in a glassy matrix of dairy proteins and glucose, the LC-PUFA preferably being derived from fish oil or algae oil.
4 . The composition according to claim 1 wherein ferric saccharate provides an amount of iron of about 0.0001% to about 1% by weight of the composition.
5 . The composition according to claim 1 , wherein the ferric saccharate is microencapsulated.
6 . The composition according to claim 1 , which contains at least one antioxidant which is a radical scavenger.
7 . The composition according to claim 1 , which contains a non-sensitive fat.
8 . The composition according to claim 1 , which is in a form selected from the group consisting of a food matrix, a beverage and a food supplement.
9 . The composition according to claim 8 , wherein the food product is a nutritional composition.
10 . The composition according to claim 1 which is a pharmaceutical composition and/or a nutraceutical product.
11 . A method for use in the prevention, amelioration or treatment of malnutrition, metabolic diseases, neurodegenerative diseases comprising administering to an individual in need of same a composition comprising a composition fortified with ferric saccharate and a high concentration of microencapsulated LC-PUFA.
12 . A method for use in the promotion of the development of the nervous system and/or of the retina, in the promotion and/or improvement of the mental performance, behavioural and visual functions of an infant or a child, for strengthening immunity, including the development of gut microflora, and/or for reducing the risk of the development of overweight, obesity and insulin resistance comprising administering to an individual in need of same a composition comprising a composition fortified with ferric saccharate and a high concentration of microencapsulated LC-PUFA.
13 . A method for preventing or reducing the oxidation of LC-PUFA in a composition comprising LC-PUFA and iron, comprising adding LC-PUFA to the composition in microencapsulated form and adding iron in the form of ferric saccharate.
14 . A method for preventing or reducing the off-taste of LC-PUFA in a composition comprising LC-PUFA and iron, comprising adding LC-PUFA to the composition in microencapsulated form and adding iron in the form of ferric saccharate, wherein preferably the LC-PUFA is microencapsulated in a glassy matrix of dairy proteins and glucose.
15 - 16 . (canceled)